• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利什曼原虫gp63中人类T细胞表位的定位。交叉反应性和种特异性表位的鉴定。

Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopes.

作者信息

Russo D M, Jardim A, Carvalho E M, Sleath P R, Armitage R J, Olafson R W, Reed S G

机构信息

Seattle Biomedical Research Institute, WA 98109.

出版信息

J Immunol. 1993 Feb 1;150(3):932-9.

PMID:7678627
Abstract

Both a conserved surface metalloprotease of leishmania, gp63 as well as certain gp63-derived peptides, have been shown to have immunoprophylactic potential in mouse models of leishmaniasis. In addition, PBMC from individuals with cutaneous, mucosal, or cured visceral leishmaniasis respond in vitro to both native and rgp63. In this report, we mapped human T cell epitopes within gp63. T cells from leishmaniasis patients responded in vitro to certain peptides of gp63 by proliferation and IFN-gamma production. One peptide, (PT7), stimulated cells from all individuals tested (n = 7). Anti-PT7 T cell lines derived from PBMC of a mucosal leishmaniasis patient contained a heterogeneous population of cells which responded by proliferation and IFN-gamma production to in vitro stimulation with Leishmania promastigote lysate. Another peptide (PT1) derived from Leishmania chagasi gp63 stimulated PBMC from an L. chagasi patient although the corresponding Leishmania major-derived peptide did not. Both L. major PT7 and L. chagasi PT1 were able to induce anti-Leishmania-specific T cell lines from normal human PBMC. These T cell lines responded to in vitro stimulation with promastigote lysate indicating that both peptides were immunogenic for naive T cells in vitro. In conclusion, both antigenic and immunogenic gp63 peptide sequences have been defined, some appearing to be conserved among Leishmania species and at least one that appears to be species specific.

摘要

利什曼原虫的一种保守表面金属蛋白酶gp63以及某些gp63衍生肽,已在利什曼病小鼠模型中显示出免疫预防潜力。此外,来自皮肤型、黏膜型或已治愈内脏型利什曼病患者的外周血单核细胞(PBMC)在体外对天然和重组gp63均有反应。在本报告中,我们绘制了gp63内的人类T细胞表位。利什曼病患者的T细胞在体外通过增殖和产生γ干扰素对gp63的某些肽作出反应。一种肽(PT7)刺激了所有受试个体(n = 7)的细胞。从一名黏膜利什曼病患者的PBMC中获得的抗PT7 T细胞系包含异质性细胞群体,这些细胞通过增殖和产生γ干扰素对利什曼原虫前鞭毛体裂解物的体外刺激作出反应。另一种源自恰加斯利什曼原虫gp63的肽(PT1)刺激了一名恰加斯利什曼病患者的PBMC,而相应的大利什曼原虫衍生肽则无此作用。大利什曼原虫PT7和恰加斯利什曼原虫PT1均能够从正常人PBMC中诱导出抗利什曼原虫特异性T细胞系。这些T细胞系对前鞭毛体裂解物的体外刺激有反应,表明这两种肽在体外对未致敏T细胞具有免疫原性。总之,已确定了具有抗原性和免疫原性的gp63肽序列,其中一些序列在利什曼原虫物种之间似乎是保守的,至少有一个序列似乎具有物种特异性。

相似文献

1
Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopes.利什曼原虫gp63中人类T细胞表位的定位。交叉反应性和种特异性表位的鉴定。
J Immunol. 1993 Feb 1;150(3):932-9.
2
Human T cell responses to gp63, a surface antigen of Leishmania.
J Immunol. 1991 Nov 15;147(10):3575-80.
3
Antigen-reactive gamma delta T cells in human leishmaniasis.人类利什曼病中的抗原反应性γδ T细胞
J Immunol. 1993 Oct 1;151(7):3712-8.
4
Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis.犬内脏利什曼病期间产生的抗体所识别的婴儿利什曼原虫gp63蛋白抗原决定簇的定位
Parasitology. 1997 Jun;114 ( Pt 6):507-16.
5
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.美洲皮肤利什曼病患者对纯化的皮氏利什曼原虫无鞭毛体抗原和巴西利什曼原虫前鞭毛体抗原的T细胞反应性:与治愈相关的免疫模式
Exp Parasitol. 1996 Nov;84(2):144-55. doi: 10.1006/expr.1996.0100.
6
Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins.利什曼原虫脂磷壁酸相关蛋白对人T淋巴细胞的刺激作用。
J Immunol. 1992 Jan 1;148(1):202-7.
7
Modification of GP63 genes from diverse species of Leishmania for expression of recombinant protein at high levels in Escherichia coli.对来自不同利什曼原虫物种的GP63基因进行改造,以便在大肠杆菌中高水平表达重组蛋白。
Mol Biochem Parasitol. 1991 Feb;44(2):213-24. doi: 10.1016/0166-6851(91)90007-s.
8
Mapping human T cell epitopes in Leishmania gp63: identification of cross-reactive and species-specific epitopes.
J Immunol. 1993 May 15;150(10):4713.
9
Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.在对日本柳杉花粉和日本扁柏花粉交叉反应的过敏患者中识别日本扁柏花粉主要过敏原Cha o 2特有的T细胞表位。
Allergol Int. 2009 Jun;58(2):237-45. doi: 10.2332/allergolint.08-OA-0027. Epub 2009 Mar 25.
10
Use of sequential oligopeptide carriers (SOCn) in the design of potent Leishmania gp63 immunogenic peptides.序列寡肽载体(SOCn)在强效利什曼原虫gp63免疫原性肽设计中的应用。
Pept Res. 1996 Sep-Oct;9(5):240-7.

引用本文的文献

1
The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.利什曼原虫的致病性和毒力——毒力因子与宿主防御的相互作用。
Virulence. 2022 Dec;13(1):903-935. doi: 10.1080/21505594.2022.2074130.
2
Vaccine Development Against Leishmania donovani.抗杜氏利什曼原虫疫苗的研制。
Front Immunol. 2012 May 15;3:99. doi: 10.3389/fimmu.2012.00099. eCollection 2012.
3
gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.稳定阳离子脂质体中的gp63赋予感染杜氏利什曼原虫的易感BALB/c小鼠持续的疫苗免疫力。
Infect Immun. 2008 Mar;76(3):1003-15. doi: 10.1128/IAI.00611-07. Epub 2008 Jan 14.
4
Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.治愈的利什曼原虫感染患者和仓鼠针对杜氏利什曼原虫近期临床分离株的整合膜蛋白和非膜溶性蛋白的免疫刺激细胞反应。
Clin Exp Immunol. 2005 Apr;140(1):149-56. doi: 10.1111/j.1365-2249.2005.02745.x.
5
Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.化疗前后免疫球蛋白G及其亚类对印度黑热病感染反应的特征分析
Infect Immun. 2004 Feb;72(2):863-70. doi: 10.1128/IAI.72.2.863-870.2004.
6
Leishmaniasis: current status of vaccine development.利什曼病:疫苗研发的现状
Clin Microbiol Rev. 2001 Apr;14(2):229-43. doi: 10.1128/CMR.14.2.229-243.2001.
7
Nonrandom spatial distribution of synonymous substitutions in the GP63 gene from Leishmania.利什曼原虫GP63基因中同义替换的非随机空间分布。
Genetics. 2000 Aug;155(4):1683-92. doi: 10.1093/genetics/155.4.1683.
8
Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis.皮氏利什曼原虫无鞭毛体抗原P-4:在人类皮肤利什曼病中参与T细胞反应性的表位
Infect Immun. 1998 Jul;66(7):3100-5. doi: 10.1128/IAI.66.7.3100-3105.1998.
9
Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis.皮肤利什曼病中硕大利什曼原虫无鞭毛体组分的生化分析及免疫原性
Clin Exp Immunol. 1997 Nov;110(2):203-11. doi: 10.1111/j.1365-2249.1997.tb08318.x.
10
Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes.表面锌蛋白酶作为墨西哥利什曼原虫亚马逊亚种前鞭毛体抵御巨噬细胞吞噬溶酶体内细胞溶解的一种分子。
Infect Immun. 1996 Dec;64(12):5129-37. doi: 10.1128/iai.64.12.5129-5137.1996.